Vessix System, a safe and effective method for the treatment of resistant hypertension

Renal Sympathetic Denervation Using a Novel Percutaneous Bipolar Radiofrequency Balloon Catheter in Patients with Resistant Hypertension

During the VIVA (Vascular InterVentional Advances) Meeting which took place in Las Vegas, Nevada, USA, on October 8 to 11, 2013, Clinical data from the REDUCE-HTN study was released. Dierk Scheinert, M.D. from Park Hospital and Heart Center in Leipzig, Germany presented the data in a late-breaking clinical trial session and also presented clinical information during a Boston Scientific sponsored renal denervation symposium.

Download the slides